Literature DB >> 49517

Lack of causal association between Coxsackie B4 virus infection and diabetes.

S E Dippe, P H Bennett, M Miller, J E Maynard, K R Berquist.   

Abstract

An epidemic of Coxsackie B4 virus infection in an isolated group of islands in the Bering Sea in 1967 provided an opportunity to test the suggestion that infection with this virus might be associated with an increased incidence of diabetes. In 1973 islanders were tested by glucose-tolerance tests and their two-hour plasma glucose levels were analysed in the light of serological evidence of CB4 infection five years earlier. There was no evidence of any increased prevalence of diabetes in those who had been infected in 1967.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49517     DOI: 10.1016/s0140-6736(75)92318-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Virus infections in type 1 diabetes.

Authors:  Ken T Coppieters; Tobias Boettler; Matthias von Herrath
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Virus-induced diabetes mellitus.

Authors:  A L Notkins
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Juvenile diabetes mellitus: possibility of prevention.

Authors:  J W Farquhar
Journal:  Arch Dis Child       Date:  1979-08       Impact factor: 3.791

5.  Course of coxsackie B antibodies during juvenile diabetes.

Authors:  W A Schmidt; L Brade; H Müntefering; M Klein
Journal:  Med Microbiol Immunol       Date:  1978       Impact factor: 3.402

6.  Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.

Authors:  V A Koivisto; A Aro; K Cantell; M Haataja; J Huttunen; S L Karonen; P Mustajoki; R Pelkonen; P Seppälä
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

7.  Human leukocyte interferon treatment of two children with insulin dependent diabetes.

Authors:  K H Rand; A L Rosenbloom; N K Maclaren; J H Silverstein; W J Riley; B E Butterworth; J W Yoon; A H Rubenstein; T C Merigan
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

8.  Pathological changes in the pancreas of mice following infection with Coxsackie B viruses.

Authors:  A B Lansdown
Journal:  Br J Exp Pathol       Date:  1976-06

9.  Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection.

Authors:  J P Palmer; M K Cooney; R H Ward; J A Hansen; J B Brodsky; C G Ray; J R Crossley; C M Asplin; R H Williams
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

10.  Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4.

Authors:  J W Yoon; T Onodera; A L Notkins
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.